A disease is considered a "rare disease" in Europe if it affects fewer than one in 2000 people, causes a lasting disability or is life-threatening. Over 7000 rare disease have been identified to date.
In radiz, a new clinical research priority program, researchers and clinicians from the Children's Hospital Zurich, the University of Zurich, and the UniversityHospital Zurich are joining forces in the field of rare diseases. radiz is being coordinated at the Children's Hospital Zurich under the auspices of the Children's Research Centre.
radiz aims to improve the treatment and outcome of patients with rare diseases and to establish Zurich as one of the leading centers in the field of rare diseases in Europe. A great emphasis is placed on the transition from pediatric to adult medicine.
The critical mass of medical, biological, and technical expertise in Zurich will allow the discovery of new rare disease entities and disease mechanisms and the development of better therapeutic strategies for rare diseases.